Anzeige
Mehr »
Samstag, 04.10.2025 - Börsentäglich über 12.000 News
Innocan Pharma: Neues Medikament für den Massenmarkt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QQEL | ISIN: CA68405H1001 | Ticker-Symbol: 8BN
Tradegate
01.10.25 | 21:22
0,230 Euro
-5,74 % -0,014
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
OPTIMI HEALTH CORP Chart 1 Jahr
5-Tage-Chart
OPTIMI HEALTH CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,2340,24813:03
0,0000,00003.10.

Aktuelle News zur OPTIMI HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.09.Optimi Health Corp: Optimi files registration station for proposed U.S. IPO2
06.09.Canada-based psychedelics manufacturer Optimi Health files for a $25 million US IPO2
05.09.Optimi Health Corp. - F-1, Registration statement for certain foreign private issuers1
03.09.Optimi Health Corp: Optimi Health launches psilocybin capsules in Australia1
03.09.Optimi Health Corp.: Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression390Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian manufacturer of GMP psychedelic...
► Artikel lesen
OPTIMI HEALTH Aktie jetzt für 0€ handeln
20.08.Optimi Health Corp: Optimi Health hires MZ for IR services2
20.08.Optimi Health Corp.: Optimi Health Provides Corporate Update330Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a manufacturer of GMP-certified MDMA and psilocybin...
► Artikel lesen
25.07.Optimi Health Corp: Optimi investor Catcher acquires $3M in debentures1
18.07.Optimi Health Corp: Optimi arranges $3.45-million debenture financing2
18.07.Optimi Health launches $3.45M convertible debenture offering1
18.07.Optimi Health Corp.: Optimi Health Announces $3.45 Million Convertible Financing and Extension of Secured Term Loan504Vancouver, British Columbia--(Newsfile Corp. - July 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian drug manufacturer and formulator of...
► Artikel lesen
08.05.Optimi Health Corp: Optimi Health exports MDMA capsules to Australia1
08.05.Optimi Health Corp.: Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy462Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian drug manufacturer and formulator of GMP-grade...
► Artikel lesen
05.05.Optimi Health Corp: Optimi Health formally recognized by U.S. FDA4
05.05.Optimi Health Corp.: Optimi Health Obtains U.S. FDA Drug Establishment Registration425Vancouver, British Columbia--(Newsfile Corp. - May 5, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a manufacturer of GMP-certified MDMA and psilocybin...
► Artikel lesen
12.03.Optimi Health Corp.: Optimi Health Provides Corporate Update377Vancouver, British Columbia--(Newsfile Corp. - March 12, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-compliant, Health Canada-licensed manufacturer...
► Artikel lesen
29.01.Optimi Health Corp.: Optimi Health Completes Largest MDMA Capsule Batch to Date, Expands Stability Program350Vancouver, British Columbia--(Newsfile Corp. - January 29, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian-based company licensed by Health...
► Artikel lesen
29.01.Optimi Health Corp.: Optimi Health Announces Closing of Non-Brokered Private Placement and Debt Settlement527Vancouver, British Columbia--(Newsfile Corp. - January 28, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psychedelics...
► Artikel lesen
17.01.Optimi Health Corp.: Optimi Health Provides Corporate Update982Vancouver, British Columbia--(Newsfile Corp. - January 17, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psychedelics...
► Artikel lesen
13.01.Optimi Health Corp.: Optimi Health Reports First Patients Dosed in Landmark Natural Psilocybin Study in New Zealand268Vancouver, British Columbia--(Newsfile Corp. - January 13, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic...
► Artikel lesen
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1